Recurrent benign prostatic hypertrophy
Steg, A.; Aboulker, P.
Progress in Clinical and Biological Research 6: 81-90
1976
ISSN/ISBN: 0361-7742 PMID: 66698 Document Number: 104950
Document emailed within 1 workday
Related Documents
Kazama, T.; Mizuno, I.; Takamine, T.; Umeda, K.; Terada, T.; Ishikawa, S.; Fuse, H.; Katayama, T. 1990: Evaluation of anti-androgen therapy for benign prostatic hypertrophy by using transrectal prostatic ultrasonography Hinyokika Kiyo. Acta Urologica Japonica 36(12): 1423-1427Schoenberg, H.W.; Kaplan, W.E. 1978: Benign prostatic hypertrophy Comprehensive Therapy 4(8): 10-17
Bellows, J.G. 1979: Phenoxybenzamine for benign prostatic hypertrophy Comprehensive Therapy 5(6): 3-4
Forti, G.; Serio, M. 1990: Gn-RH analogs and benign prostatic hypertrophy Drugs under Experimental and Clinical Research 16(Suppl): 31-32
Romics, I. 2003: Treatment of benign prostatic hypertrophy Orvosi Hetilap 144(45): 2229-2230
Castro, J.E.; Griffiths, H.L. 1972: The assessment of patients with benign prostatic hypertrophy Journal of the Royal College of Surgeons of Edinburgh 17(3): 190-194
Martini, E.; Vaggi, L.; Rucci, A.; Di Clemente, L. 1994: Non-surgical treatment of benign prostatic hypertrophy Journal de Chirurgie 131(10): 445-449
Schulman, C.C. 1993: Surgical treatment of benign prostatic hypertrophy European Urology 23(2): 261
Nix, J.W.; Carson, C.C. 2007: Medical management of benign prostatic hypertrophy Canadian Journal of Urology 14(Suppl 1): 53-57
Grisard, S.; Long, J.-A. 2018: Benign prostatic hypertrophy, bladder hyperactivity and anticholinergic La Revue du Praticien 68(4): E148
Narayan, J.P.; Srivastava, S.P.; Singh, J.N. 1985: Free estrogens and progestogens in benign prostatic hypertrophy Indian Journal of Physiology and Pharmacology 29(2): 119-122
McRae, L.P.; Bottaccini, M.R.; Gleason, D.M. 1995: Objective noninvasive evaluation of benign prostatic hypertrophy Biomedical Instrumentation and Technology 29(1): 50-54
Verlooy, J.; van Sande, M.; Van Camp, K. 1980: Aldolase activity in benign prostatic hypertrophy and adenocarcinomatous prostate Acta Urologica Belgica 48(1): 65-67
Hanus, M.; Matousková, M. 1993: Alternative therapy of benign prostatic hypertrophy--Permixon (Capistan) Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 72(2): 75-79
Larosa, M.; Ferretti, S.; Salsi, P.; Simonazzi, M. 1994: Use of terazosin and alfuzosin in the treatment of benign prostatic hypertrophy (BPH): our experience Acta Bio-Medica de l'Ateneo Parmense 65(1-2): 23-28
Hermieu, J.F.; Ravery, V.; Le Coent, R.; Delmas, V.; Boccon-Gibod, L. 1998: Effects of a 6F urethral catheter on uroflowmetry in men with benign prostatic hypertrophy Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 8(6): 1035-1038
Fujita, K.; Sayama, T.; Abe, S.; Murayama, T.; Sugimoto, M.; Hara, T. 1985: A pharmacokinetic study of antibiotics in patients with benign prostatic hypertrophy Japanese Journal of Antibiotics 38(8): 2145-2148
Nakajima, H.; Yui, Y.; Akimoto, M. 1985: Clinical evaluation of surgical treatment for benign prostatic hypertrophy Hinyokika Kiyo. Acta Urologica Japonica 31(1): 101-106
Karanth, N.S.; Crausman, R.S.; De Palo, V.A. 2005: Deep venous thrombosis as a consequence of benign prostatic hypertrophy Medicine and Health Rhode Island 88(1): 18-19
Giurioli, A.; Rosi, P.; Parziani, S.; Cesaroni, M.; Ghamari, M.R. 1988: Treatment of benign prostatic hypertrophy using mepartricin at high dosage Minerva Urologica e Nefrologica 40(2 Suppl): 38-39